Unique SMAD4 mutations, as well as recurrent changes, with more than 60% of them being novel, were reported in 64 out of 744 sporadic CRC patients (8.6%) treated in hospitals across Australia. The gene discussed is SMAD4; the disease is colorectal carcinoma.